They found that the upregulation of ITGB2 in NSCLC cell lines increased the expression of immune-related proteins, such as N-cadherin, snail, and slug, while decreasing the E-cadherin expression, laying the foundation for further research on immunotherapy. The gene discussed is ITGB2; the disease is non-small cell lung carcinoma.